EUVIMEDEUVIMED entdecken
Open Access

ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation

Jiayida Nulali, Kaiwen Zhang, Manmei Long, Yueyue Wan, Yu Liu, Qianyue Zhang, Liu Yang, Jun Hao, Linhua Yang, Huaidong Song

International Journal of Biological Sciences · 2024 · 20 (1) · 331-346

DOI: 10.7150/ijbs.82316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Jiayida Nulali und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Core Laboratory in Medical Center of Clinical Research, Department of Molecular Diagnostics and Endocrinology, Shanghai Ninth People's Hospital, …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-Methylcytosine (m5C) is one of the most ubiquitous modifications of mRNA and contributes to cancer pathogenesis. Aly/REF export factor (ALYREF), an m5C reader, is associated with the prognosis of liver hepatocellular carcinoma (LIHC). However, the effects of ALYREF on the progression of LIHC and the underlying molecular mechanisms remains elusive. Through an analysis of an online database and 3 independent LIHC cohorts, we found that ALYREF was markedly elevated in human liver cancer tissues and was significantly correlated with LIHC clinicopathological parameters, including Ki67+ cell rate, high-grade TNM stage, and poor prognosis. Several experiments were conducted to investigate the molecular basis and functional role of ALYREF-related progression in this study. ALYREF could enhance LIHC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) in vitro and tumor formation in vivo. Mechanistically, ALYREF promoted the progression of human LIHC through EGFR pathways. Furthermore, ALYREF could directly bind to the m5C modification site of EGFR 3' untranslated region (3' UTR) to stabilize EGFR mRNA. Collectively, ALYREF played a crucial oncogenic role in LIHC via the stabilization of EGFR mRNA and subsequent activation of the STAT3 signaling pathway. Our results may help to elucidate the potential mechanisms of ALYREF-induced m5C modification in the progression of human LIHC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumans5-MethylcytosineRNA, Messenger3' Untranslated RegionsErbB ReceptorsNuclear ProteinsTranscription FactorsRNA-Binding Proteins

Stichwörter der Autor:innen

Aly/REF export factor (ALYREF)EGFREpithelial-mesenchymal transition (EMT)Liver hepatocellular carcinoma (LIHC)M5-methyladenosine (m5C)

Substanzen

5-MethylcytosineRNA, Messenger3' Untranslated RegionsErbB ReceptorsALYREF protein, humanNuclear ProteinsTranscription FactorsRNA-Binding ProteinsEGFR protein, human

Autor:innen und Institutionen

  • The Core Laboratory in Medical Center of Clinical Research, Department of Molecular Diagnostics and Endocrinology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, Ch…
  • Department of Pathology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Department of Respiration, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Zitieren

APA

Nulali, J., Zhang, K., Long, M., Wan, Y., Liu, Y., Zhang, Q., Yang, L., Hao, J., Yang, L., & Song, H. (2024). ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation. International Journal of Biological Sciences, 20(1), 331-346. https://doi.org/10.7150/ijbs.82316

Vancouver

Nulali J, Zhang K, Long M, Wan Y, Liu Y, Zhang Q, et al. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation. International Journal of Biological Sciences. 2024;20(1):331-346. doi:10.7150/ijbs.82316

BibTeX
@article{Nulali2024,
  author = {Nulali, Jiayida and Zhang, Kaiwen and Long, Manmei and Wan, Yueyue and Liu, Yu and Zhang, Qianyue and Yang, Liu and Hao, Jun and Yang, Linhua and Song, Huaidong},
  title = {ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation},
  journal = {International Journal of Biological Sciences},
  year = {2024},
  volume = {20},
  number = {1},
  pages = {331--346},
  doi = {10.7150/ijbs.82316}
}
Kostenlos starten →